Article
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype.
EMBO molecular medicine - 7 Oct 2021
Soldati Chiara, Lopez-Fabuel Irene, Wanderlingh Luca G, Garcia-Macia Marina, Monfregola Jlenia, Esposito Alessandra, Napolitano Gennaro, Guevara-Ferrer Marta, Scotto Rosato Anna, Krogsaeter Einar K, Paquet Dominik, Grimm Christian M, Montefusco Sandro, Braulke Thomas, Storch Stephan, Mole Sara E, De Matteis Maria A, Ballabio Andrea, Sampaio Julio L, McKay Tristan, Johannes Ludger, Bolaños Juan P, Medina Diego L
Abstract excerpt
Batten diseases (BDs) are a group of lysosomal storage disorders characterized by seizure, visual loss, and cognitive and motor deterioration. We discovered increased levels of globotriaosylceramide (Gb3) in cellular and murine models of CLN3 and CLN7 diseases and used fluorescent-conjugated bacterial toxins to label Gb3 to develop a cell-based high content imaging (HCI) screening assay for the repurposing of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
